Christine Posted October 17, 2007 Share Posted October 17, 2007 Wed Oct 17, 2007 11:15am EDT Oct 17 (Reuters) - Poniard Pharmaceuticals Inc (PARD.O: Quote, Profile, Research) said the European Commission granted its drug, picoplatin, orphan drug status for the treatment of small cell lung cancer. This designation is given to drugs which may be used for conditions that affect no more than five in 10,000 persons in the European Union, the biopharmaceutical company said in a statement. Poniard said Wednesday's status for the drug, which already has orphan drug status in the United States for the same condition, is based on the recommendation from a committee of the health regulator European Medicines Agency (EMEA). (Reporting by Varsha Tickoo in Bangalore) Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.